Cite

HARVARD Citation

    Hedskog, C. et al. (n.d.). 1149. Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1). Open forum infectious diseases. p. . [Online]. 
  
Back to record